| Merkel cell carcinoma: epidemiology, prognosis, therapy and unmet medical needs D Schadendorf, C Lebbé, A Zur Hausen, MF Avril, S Hariharan, ... European journal of cancer 71, 53-69, 2017 | 447 | 2017 |
| Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications M Bharmal, K Payne, MJ Atkinson, MP Desrosiers, DE Morisky, ... Health and quality of life outcomes 7, 1-10, 2009 | 313 | 2009 |
| Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States RP Allen, M Bharmal, M Calloway Movement Disorders 26 (1), 114-120, 2011 | 269 | 2011 |
| National Trends in Staphylococcus aureus Infection Rates: Impact on Economic Burden and Mortality over a 6-Year Period (1998–2003) GA Noskin, RJ Rubin, JJ Schentag, J Kluytmans, EC Hedblom, ... Clinical Infectious Diseases 45 (9), 1132-1140, 2007 | 269 | 2007 |
| Incremental direct expenditure of treating asthma in the United States S Kamble, M Bharmal Journal of Asthma 46 (1), 73-80, 2009 | 235 | 2009 |
| Comparing the EQ‐5D and the SF‐6D descriptive systems to assess their ceiling effects in the US general population M Bharmal, J Thomas III Value in Health 9 (4), 262-271, 2006 | 207 | 2006 |
| Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma P Nghiem, HL Kaufman, M Bharmal, L Mahnke, H Phatak, JC Becker Future oncology 13 (14), 1263-1279, 2017 | 183 | 2017 |
| Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA CL Cowey, L Mahnke, J Espirito, C Helwig, D Oksen, M Bharmal Future oncology 13 (19), 1699-1710, 2017 | 136 | 2017 |
| Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe JC Becker, E Lorenz, S Ugurel, TK Eigentler, F Kiecker, C Pföhler, ... Oncotarget 8 (45), 79731, 2017 | 98 | 2017 |
| Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001: comparison of three explicit criteria H Viswanathan, M Bharmal, J Thomas III Clinical therapeutics 27 (1), 88-99, 2005 | 87 | 2005 |
| Health insurance coverage and health-related quality of life: analysis of 2000 medical expenditure panel survey data M Bharmal, J Thomas Journal of Health Care for the Poor and Underserved 16 (4), 643-654, 2005 | 53 | 2005 |
| Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals GA Noskin, RJ Rubin, JJ Schentag, J Kluytmans, EC Hedblom, ... Infection Control & Hospital Epidemiology 29 (1), 16-24, 2008 | 41 | 2008 |
| Survey of pharmacist collaborative drug therapy management in hospitals J Thomas III, M Bharmal, SW Lin, Y Punekar American journal of health-system pharmacy 63 (24), 2489-2499, 2006 | 39 | 2006 |
| Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma HL Kaufman, M Hunger, M Hennessy, M Schlichting, M Bharmal Future Oncology 14 (3), 255-266, 2017 | 28 | 2017 |
| Validation of a Women’s Sexual Interest Diagnostic Interview—short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual … LR DeRogatis, A Allgood, P Auerbach, D Eubank, J Greist, M Bharmal, ... The journal of sexual medicine 7 (2_Part_2), 917-927, 2010 | 28 | 2010 |
| Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma SP D’Angelo, M Hunger, AS Brohl, P Nghiem, S Bhatia, O Hamid, ... Cancer Immunology, Immunotherapy 68, 609-618, 2019 | 26 | 2019 |
| Cost effectiveness of avelumab for metastatic Merkel cell carcinoma A Bullement, P Nathan, A Willis, A Amin, C Lilley, C Stapelkamp, ... PharmacoEconomics-open 3, 377-390, 2019 | 25 | 2019 |
| Impact of patient selection criteria on prevalence estimates and prevalence of diagnosed dementia in a Medicaid population MF Bharmal, M Weiner, LP Sands, H Xu, BA Craig, J Thomas III Alzheimer Disease & Associated Disorders 21 (2), 92-100, 2007 | 25 | 2007 |
| Incremental dementia-related expenditures in a medicaid population MF Bharmal, S Dedhiya, BA Craig, M Weiner, M Rosenman, LP Sands, ... The American Journal of Geriatric Psychiatry 20 (1), 73-83, 2012 | 23 | 2012 |
| Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study S Bhatia, P Nghiem, SP Veeranki, A Vanegas, K Lachance, L Tachiki, ... Journal for immunotherapy of cancer 10 (8), 2022 | 21 | 2022 |
